Filing Date | Form | Description | Issuer | View |
---|---|---|---|---|
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
144 |
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
144 |
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
144 |
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Intellia Therapeutics, Inc. | ||
DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
PRE 14A |
A preliminary proxy statement providing notification matters to be brought to a vote |
Intellia Therapeutics, Inc. | ||
ARS |
An annual report to security holders |
Intellia Therapeutics, Inc. | ||
3 |
Initial filing by director officer or owner of more than ten percent. |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
10-K |
Annual report which provides a comprehensive overview of the company for the past year |
Intellia Therapeutics, Inc. | ||
S-8 |
Securities offered to employees pursuant to employee benefit plans |
Intellia Therapeutics, Inc. | ||
SC 13G/A |
An amendment to the SC 13G filing |
Intellia Therapeutics, Inc. | ||
SC 13G/A |
An amendment to the SC 13G filing |
Intellia Therapeutics, Inc. | ||
SC 13G/A |
An amendment to the SC 13G filing |
Intellia Therapeutics, Inc. | ||
SC 13G |
A statement of beneficial ownership of common stock by certain persons |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. |
Data provided by Kaleidoscope.